CA Shirima, C Bleotu, DA Spandidos… - Oncology …, 2024 - spandidos-publications.com
Head and neck squamous cell carcinomas (HNSCCs), a heterogeneous group of cancers that arise from the mucosal epithelia cells in the head and neck areas, present great …
J Chahoud, NM Zacharias, R Pham, W Qiao, M Guo… - Cancers, 2022 - mdpi.com
Simple Summary Penile Squamous Cell Carcinoma (PSCC) is a rare but aggressive cancer and approximately 30–50% of cases are associated with high risk human papillomavirus …
M Knebel, S Körner, JP Kühn, S Wemmert… - Frontiers in …, 2023 - frontiersin.org
Background Due to the expanding role of immune checkpoint inhibition in the treatment of head and neck squamous cell carcinoma, understanding immunological processes in the …
Background Personalized treatment is increasingly required for oropharyngeal squamous cell carcinoma (OPSCC) patients due to emerging new cancer subtypes and treatment …
AK Struckmeier, A Radermacher, M Fehrenz… - Journal of Cancer …, 2023 - Springer
Abstract Purpose Strategies for Indolamine-2, 3-dioxygenase 1 (IDO1) inhibition in cancer immunotherapy once produced encouraging results, but failed in clinical trials. Recent …
S Körner, T Pick, F Bochen, S Wemmert… - Frontiers in …, 2022 - frontiersin.org
Various cancer types including head and neck squamous cell carcinomas (HNSCC) show a frequent amplification of chromosomal region 3q26 that encodes, among others, for the …
AK Struckmeier, A Radermacher, M Fehrenz… - Cancers, 2022 - mdpi.com
Simple Summary Triggering receptor expressed on myeloid cells 2 (TREM2) is an appealing candidate for immunotherapy. However, results regarding its role in multiple cancers are …
Background and purpose To compare the prediction performance of image features of computed tomography (CT) images extracted by radiomics, self-supervised learning and …
G Huang, H Gao, Y Chen, W Lin, J Shen… - Journal of …, 2023 - Taylor & Francis
Purpose The platelet-to-lymphocyte ratio (PLR) is considered correlated with cancer prognosis including cervical cancer, in addition to high-risk papillomavirus (HR-HPV) …